Cargando…

Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy

Detalles Bibliográficos
Autores principales: Zhou, Xiaoshan, Dai, Haoran, Jiang, Hanxue, Rui, Hongliang, Liu, Wenbin, Dong, Zhaocheng, Zhang, Na, Zhao, Qihan, Feng, Zhendong, Hu, Yuehong, Hou, Fanyu, Zheng, Yang, Liu, Baoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010436/
https://www.ncbi.nlm.nih.gov/pubmed/36923355
http://dx.doi.org/10.3389/fphar.2023.1166591
_version_ 1784906176552501248
author Zhou, Xiaoshan
Dai, Haoran
Jiang, Hanxue
Rui, Hongliang
Liu, Wenbin
Dong, Zhaocheng
Zhang, Na
Zhao, Qihan
Feng, Zhendong
Hu, Yuehong
Hou, Fanyu
Zheng, Yang
Liu, Baoli
author_facet Zhou, Xiaoshan
Dai, Haoran
Jiang, Hanxue
Rui, Hongliang
Liu, Wenbin
Dong, Zhaocheng
Zhang, Na
Zhao, Qihan
Feng, Zhendong
Hu, Yuehong
Hou, Fanyu
Zheng, Yang
Liu, Baoli
author_sort Zhou, Xiaoshan
collection PubMed
description
format Online
Article
Text
id pubmed-10010436
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100104362023-03-14 Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy Zhou, Xiaoshan Dai, Haoran Jiang, Hanxue Rui, Hongliang Liu, Wenbin Dong, Zhaocheng Zhang, Na Zhao, Qihan Feng, Zhendong Hu, Yuehong Hou, Fanyu Zheng, Yang Liu, Baoli Front Pharmacol Pharmacology Frontiers Media S.A. 2023-02-27 /pmc/articles/PMC10010436/ /pubmed/36923355 http://dx.doi.org/10.3389/fphar.2023.1166591 Text en Copyright © 2023 Zhou, Dai, Jiang, Rui, Liu, Dong, Zhang, Zhao, Feng, Hu, Hou, Zheng and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhou, Xiaoshan
Dai, Haoran
Jiang, Hanxue
Rui, Hongliang
Liu, Wenbin
Dong, Zhaocheng
Zhang, Na
Zhao, Qihan
Feng, Zhendong
Hu, Yuehong
Hou, Fanyu
Zheng, Yang
Liu, Baoli
Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy
title Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy
title_full Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy
title_fullStr Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy
title_full_unstemmed Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy
title_short Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy
title_sort corrigendum: micrornas: potential mediators between particulate matter 2.5 and th17/treg immune disorder in primary membranous nephropathy
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010436/
https://www.ncbi.nlm.nih.gov/pubmed/36923355
http://dx.doi.org/10.3389/fphar.2023.1166591
work_keys_str_mv AT zhouxiaoshan corrigendummicrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT daihaoran corrigendummicrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT jianghanxue corrigendummicrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT ruihongliang corrigendummicrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT liuwenbin corrigendummicrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT dongzhaocheng corrigendummicrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT zhangna corrigendummicrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT zhaoqihan corrigendummicrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT fengzhendong corrigendummicrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT huyuehong corrigendummicrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT houfanyu corrigendummicrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT zhengyang corrigendummicrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy
AT liubaoli corrigendummicrornaspotentialmediatorsbetweenparticulatematter25andth17tregimmunedisorderinprimarymembranousnephropathy